• Initiatives
    • OB Emergency Readiness
    • TeamBirth
    • OMNO
    • Maternal Morbidity and Mortality
    • Low Dose Aspirin
    • Infant Mortality
    • Newborn Screening
    • Hospital Recognition
    • Completed Initiatives
  • Professionals
    • Resources
    • OPNF
    • Legislation
  • Patients
    • Resources
    • Lived Experience Program
    • Map Directory
  • About
    • Faculty and Staff
    • Contact Us
  • Events
  • What’s New

OHCA Provider Letter: Makena® and Vaginal Progesterone Coverage

OHCA Provider Letter: Makena® and Vaginal Progesterone Coverage

Category: Maternal IssuesTags: makena, progesterone
July 25, 2016
The Oklahoma Health Care Authority (OHCA) is expanding coverage of Makena® and vaginal progesterone effective August 1, 2016. The expanded coverage is an effort to decrease the number of preterm births in Oklahoma.  Click here to view the provider letter.

Post navigation

PreviousNext

Recent Posts

  • NIH: Understanding Our Patients Through a Trauma-Informed Lens
  • NWH: A Systemwide Postpartum Inpatient Maternal Mental Health Education and Screening Program
  • CDC: Births: Provisional Data for 2022
  • AJOG: Special Issue – Labor and Delivery 
  • Medical Mistrust Among Pregnant Women During the COVID-19 Pandemic
405 271 7777
920 Stanton L Young Blvd
G. Rainey Williams Pavilion
room WP-2230
Oklahoma City, OK 73104
  • Patients
    • Patient Resources
    • Lived Experience
    • Resource Map
    • OPQIC Initiatives
  • Professionals
    • What's New
    • Resources
    • OPNF
  • Initiatives
    • TeamBirth
    • ED OB Readiness
    • OMNO
    • Infant Mortality
  • About
    • Contact Us
    • Subscribe
Sign up for our monthly newsletter
Sitemap | © 2014-2023 Oklahoma Perinatal Quality Improvement Collaborative. All Rights Reserved.